Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Venus Remedies receives Saudi FDA approval for Plerixafor
Venus Remedies has received Marketing Authorization from the Saudi Food and Drug Authority (SFDA) for Plerixafor. This is the first Marketing Authorization Venus Remedies has secured for Plerixafor anywhere in the world. It is also a deliberate step in the company's move toward complex, higher-value specialty injectables in oncology and critical care, replacing reliance on commodity injectable volumes with diifferentiated therapies in regulated markets.
Momentum Stocks: Solex Energy, Sagardeep Alloy, Grand Continent rally sheer momentum
A few stocks saw sharp intraday moves and hit upper circuits. Venus Remedies, Modison, Gujarat Raffia Industries, GE Power India were locked in the upper band, reflecting strong demand and limited supply—often a sign of bullish near-term sentiment.